Topic: Kratom

13 chapters across the catalog

Lunar Economy
Episode 1872 2:08:04 - 2:10:39

1872: Lunar Economy

Boots on the Ground, Flavored Vapes CDC Resignation

"Boots on the ground" reports suggest that a high-ranking CDC official resigned because Donald Trump forced the approval of flavored vapes. Other listener feedback covers the use of kratom and the "government teat." The hosts emphasize the importance of these field reports in providing information not covered by mainstream media.

Hatman
Episode 1871 1:40:55 - 1:45:30

1871: Hatman

Kratom Ban, Tennessee Legislation, AI Lawsuit

Tennessee has passed a ban on Kratom, a Southeast Asian plant often used to manage pain or opioid addiction. The legislation follows a controversial case involving a teenager's death, though a toxicology report suggests a lethal dose of Benadryl was the primary cause. Lawmakers cited concerns over synthetic "7-hydroxy" versions of the plant, which are significantly more potent than morphine.

Lubio
Episode 1868 2:01:49 - 2:06:41

1868: Lubio

ChatGPT Wrongful Death Lawsuit Over Drug Overdose

The family of Sam Nelson is suing OpenAI, alleging that ChatGPT 4.0 provided lethal advice that led to the teenager's fatal drug overdose. The chatbot reportedly told Nelson it was safe to combine Kratom and Xanax. OpenAI expressed sympathy but noted the interactions occurred on an older version of the software. The hosts discuss the liability issues of AI and the responsibility of parents in monitoring tech usage.

chatJCD
Episode 1788 2:01:37 - 2:04:29

1788: chatJCD

Kratom Chemistry and Opioid Definitions

An ER nurse provides a technical breakdown of Kratom, distinguishing between the alkaloids mitragynine and the more potent 7-hydroxymitragynine (7-OH). While Kratom is a partial opioid agonist, it is distinguished from "opiates" derived directly from the poppy plant. The 7-OH variant is noted for having more severe withdrawal symptoms.

O.G. Daffy
Episode 1787 1:20:07 - 1:27:29

1787: O.G. Daffy

Kratom Synthetic 7-OH, FDA Vape Shop Crackdown

The FDA is launching a "big action" against vape shops selling 7-OH, a synthetic derivative of the kratom plant. Dr. Marty Makary claims the product binds to opioid receptors 13 times more potently than natural kratom and has been linked to teen addiction. The hosts debate the botanical nature of kratom and criticize the FDA for targeting a plant used for centuries in Asia while ignoring other public health crises.

Vermox
Episode 1592 1:42:48 - 1:53:17

1592: Vermox

Executive Producer Donations and Star Hill Hemp Promotion

The show acknowledges high-tier donations from producers, including a $1,000 contribution from James Jackson and David from Scottsdale. Star Hill Hemp is featured for offering a "DUCKIT22" discount code to listeners, with a portion of sales going back to the show. The segment also touches on the health concerns of producers regarding "turbo cancer" and heart attacks in their communities.

X-Ray Specs
Episode 1574 1:25:52 - 1:29:08

1574: X-Ray Specs

Adrenochrome and Fear and Loathing in Las Vegas

Following comments from listeners, the hosts discuss the chemical compound adrenochrome and its portrayal in the film "Fear and Loathing in Las Vegas." While one host expresses skepticism about its alleged use in elite circles, he jokingly offers to try it if a listener sends some to the show's PO box. The conversation briefly compares the substance to the herbal supplement kratom.

4 No Youth
Episode 1573 2:22:21 - 2:24:05

1573: 4 No Youth

Kratom Experiment and FDA Warnings

One host discusses their ongoing experiment with Kratom, noting that while the FDA warns of its dangers, many people use it to successfully transition off of harder opioids. They clarify that they are not "strung out" but enjoy the "groovy" feeling it provides while watching television. They distinguish between high-quality leaves and the "micro powder" found in head shops.

Chop Shop
Episode 1572 3:00:16 - 3:04:27

1572: Chop Shop

Kratom Regulation, Health Effects and Personal Experience

Kratom, an herbal drug with opioid-like effects, is facing increased regulation and wrongful death lawsuits in the US. While some users report a euphoric boost in energy, others experience significant withdrawal symptoms, stomach issues, and cognitive impairment. One of the hosts shared a personal anecdote about trying a home-bottled version of the product, describing a "pleasant body buzz."

Afghaniscam
Episode 1379 1:36:27 - 1:40:36

1379: Afghaniscam

Producer Credits, Paradox Shop and Kratom

Producers from Seattle and Portland contributed to the show, including William Ackerman, owner of Paradox shops. Ackerman highlighted the FDA's ongoing efforts to regulate Kratom and encouraged listeners to support the natural product as an alternative to opioids.

LibJoe
Episode 1022 1:49:53 - 1:51:56

1022: LibJoe

Kratom FDA Warning, Salmonella Outbreak

The FDA and CDC have issued warnings against the use of Kratom, citing potential salmonella contamination and its properties as an opioid. While advocates use the herb to treat chronic pain and opioid withdrawal, the DEA is considering reclassifying it as a Schedule I drug. The hosts discuss the ongoing debate over the regulation of natural supplements.

Quantum of Evidence
Episode 863 1:03:07 - 1:09:38

863: Quantum of Evidence

Kratom DEA Ban, Herbal Medicine Controversy

The DEA has temporarily halted its plan to classify Kratom as a Schedule I substance following public outcry and a White House petition. Listeners share testimonials about using the herbal leaf to manage chronic pain and successfully detox from pharmaceutical opioids.

Otherizing
Episode 862 26:08 - 33:33

862: Otherizing

DEA Kratom Ban, Big Pharma Patent Interests

The DEA announced an emergency scheduling of Kratom as a Schedule 1 substance, effectively banning the Southeast Asian leaf used by many Americans for pain management and opioid withdrawal. Critics argue the ban was fast-tracked to bypass public comment and protect the interests of pharmaceutical companies developing synthetic versions of Kratom's alkaloids. Reports suggest Kratom has helped users successfully transition off oxycodone, posing a threat to traditional pain medication markets.